<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Räber, Lorenz</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">IBIS-4: High-Dose Rosuvastatin Reduces Plaque Burden in Patients with STEMI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">19-24</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents results from the Integrated Biomarker and Imaging Study-4 [IBIS-4; Räber L et al. Eur Heart J. 2014], a prospective substudy embedded in the COMFORTABLE trial [Räber L et al. JAMA. 2012] comparing biolimus-eluting stents vs bare-metal stents in patients with STEMI undergoing percutaneous coronary intervention (PCI).</style></abstract><number><style face="normal" font="default" size="100%">27</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>